Grantham, Mayo, Van Otterloo & Co (GMO)’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$826M Buy
4,425,552
+321,519
+8% +$66.6M 2.11% 16
2025
Q4
$1.09B Buy
4,104,033
+293,398
+8% +$72.9M 2.78% 9
2025
Q3
$903M Buy
3,810,635
+853,160
+29% +$215M 2.55% 12
2025
Q2
$806M Buy
2,957,475
+290,665
+11% +$77.7M 2.43% 12
2025
Q1
$716M Buy
2,666,810
+443,897
+20% +$138M 2.26% 14
2024
Q4
$743M Sell
2,222,913
-35,400
-2% -$11.3M 2.42% 12
2024
Q3
$618M Buy
2,258,313
+140,639
+7% +$36M 1.94% 19
2024
Q2
$544M Buy
2,117,674
+133,503
+7% +$35.7M 1.84% 20
2024
Q1
$598M Buy
1,984,171
+309,341
+18% +$89.3M 2.17% 16
2023
Q4
$441M Buy
1,674,830
+214,826
+15% +$48.6M 1.94% 14
2023
Q3
$296M Buy
1,460,004
+27,747
+2% +$6M 1.4% 21
2023
Q2
$303M Buy
1,432,257
+67,050
+5% +$13.7M 1.4% 21
2023
Q1
$273M Sell
1,365,207
-20,315
-1% -$3.43M 1.39% 18
2022
Q4
$184M Buy
1,385,522
+113,474
+9% +$16.6M 0.98% 28
2022
Q3
$183M Buy
1,272,048
+4,300
+0.3% +$729K 1.06% 27
2022
Q2
$209M Buy
1,267,748
+388,302
+44% +$68.6M 1.13% 22
2022
Q1
$187M Buy
879,446
+99,397
+13% +$21.4M 0.9% 29
2021
Q4
$198M Buy
780,049
+10,689
+1% +$3M 0.95% 27
2021
Q3
$209M Buy
769,360
+35,188
+5% +$8.94M 1.03% 24
2021
Q2
$179M Buy
734,172
+1,966
+0.3% +$453K 0.89% 29
2021
Q1
$155M Sell
732,206
-15,571
-2% -$3.47M 0.85% 31
2020
Q4
$166M Buy
747,777
+348,349
+87% +$84.7M 1.02% 32
2020
Q3
$100M Buy
+399,428
New +$87.4M 0.71% 36

Other funds holding CRM

Grantham, Mayo, Van Otterloo & Co (GMO)'s CRM Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Salesforce (CRM) stake by 7.8% in Q1 2026, buying an estimated $66.6M and bringing the position to 4,425,552 shares worth $826M. The position accounts for 2.11% of the portfolio, ranked #16.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CRM in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.09B in Q4 2025. 2,671 funds tracked by Wall St. Rank hold CRM as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 4,425,552 shares of Salesforce worth $826M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 321,519 Salesforce shares in Q1 2026, an estimated $66.6M.
  • Salesforce made up 2.11% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #16 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Salesforce in Q3 2020 and has held it in 23 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Salesforce position peaked at $1.09B in Q4 2025.
  • 2,671 funds tracked by Wall St. Rank held Salesforce as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.